Breast Pain
Author:
Publisher
Springer International Publishing
Link
http://link.springer.com/content/pdf/10.1007/978-3-030-13636-9_13
Reference4 articles.
1. Gong C, et al. A double-blind randomized controlled trial of toremifen therapy for Mastalgia. Arch Surg. 2006;141:43–7. Toremifen citrate has been shown to be effective in relieving the moderate and severe symptoms of cyclic mastalgia, in addition to improving non-cyclic breast pain. Its highest favorable point, relative to tamoxifen, is the lowest rate of side effects
2. Goyal A, Mansel RE. A randomized multicenter study of gamolenic acid (Efamast) with and without antioxidant vitamins and minerals in the management of mastalgia. Breast J. 2005;11(1):41–7. 555 women with moderate to severe symptoms of cyclic mastalgia were randomized into four treatment groups: gamma-Linolenic acid and antioxidants, fatty acids and antioxidants, gamma-Linolenic acid and placebo, fatty acids and placebo. There was similar reduction of symptoms in the four groups. This study observed that the use of gamma-Linolenic acid did not differ in efficacy when compared to the use of placebos.
3. Mansel R, Goyal A, Le Nestour E, Marsini-Etévé V, O’Connell K, Afimoxifene (4-OHT) Breast Pain Research Group. A phase II trial of Afimoxifene (4-hydroxytamoxifen gel) for cyclical mastalgia in premenopausal women. Breast Cancer Res Treat. 2007;106(3):389–97. Afimoxifene is a new antiestrogenic agent with a unique metabolic effect, and with a significant reduction of the mammary symptomatology. An attractive characteristic it presents is decrease of the side effects in relation to tamoxifen, since it does not undergo metabolism of the first hepatic passage.
4. Srivastava A, Mansel RE, Arvind N, Prasad K, Dhar A, Chabra A. Evidence-based management of Mastalgia: a meta-analysis of randomised trials. Breast. 2007;16:503–12. Danazol, bromocriptine and tamoxifen are drugs that offer relative relief from the symptoms of mastalgia. No study compared the efficacy of the drugs to each other, but tamoxifen in small doses is the drug of choice. The use of gamma-Linolenic acid derivatives still lacks reliable studies.
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3